🇺🇸 FDA
Pipeline program

Ferinject 50 mg/ml dispersión inyectable y para perfusión

HI-COR-65

Approved small_molecule active

Quick answer

Ferinject 50 mg/ml dispersión inyectable y para perfusión for Acute coronary syndrome is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).

Program details

Company
The George Institute
Indication
Acute coronary syndrome
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials